The NITRONAV brand, founded in 2011 (United States), from 2466 sister brands and 17477 competing brands. The NITRONAV brand is owned by JOHNSON & JOHNSON, a company listed in New York. NITRONAV is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(NITRONAV)
over 5 years*
USD 161.71